 |
|
|
||||||||||||||
 |
|
|
Know your risk by knowing your score
Diabetes can affect your body long before it is typically diagnosed. By the time the disease is diagnosed through high glucose levels in your blood, substantial damage may have already occurred.
The revolutionary PreDx™ Diabetes Risk Test gives you a PreDx™ Diabetes Risk Score — a personalized diabetes prediction score that lets you and your physician know your risk of progressing to Type 2 diabetes within 5 years.
It also gives you something new — information that can help change your future.
*Performed exclusively by the Tethys Clinical Laboratory
Nov 9, 2009
Tethys Bioscience Raises $25 Million in Series D Financing
The financing round is led by aeris Capital with George Rehm taking a seat on the Tethys board.
Oct 20, 2009
Gazing into the Future
(Journal of Life Sciences, Fall 2009)
Sep 24, 2009
A preemptive strike on diabetes: Emeryville's Tethys Biosciences rolls out pre-diabetes test
Tethys Bioscience featured in the September/October 2009 issue of Healthcare Journal of Northern California.
Aug 31, 2009
Personnel Additions and Promotions at Tethys Bioscience
Management Team in Position for Full Commercialization of its Line of Personalized-Prevention Diagnostics
Jul 15, 2009
Peer-Reviewed Publications Demonstrate Tethys Bioscience's Ability to Identify those at Highest Risk of Developing Type 2 Diabetes within Five Years
Diabetes journals publish two definitive papers supporting both the science behind and the clinical performance of lead product, the PreDx™ Diabetes Risk Score (DRS)
Jun 7, 2009
New Data in Support of Tethys Bioscience's PreDx™ Diabetes Risk Score Presented at ADA Scientific Sessions
New data support cost-effectiveness and clinical utility of a risk assessment test for type 2 diabetes